The Latest Cardiac and Vascular News
DOVER, Del.–(BUSINESS WIRE)–Mana Capital Acquisition Corp. (“Mana Capital”) (Nasdaq: MAAQU; MAAQ; MAAQW; MAAQR), a publicly traded special purpose acquisition company, today announced that its registration statement on Form S-4, relating to the previously announced business combination between Mana Capital and […]
CHICAGO, Sept. 21, 2022 /PRNewswire/ — Cardio Diagnostics, Inc. (“Cardio Diagnostics” or the “Company”), a pioneering precision cardiovascular testing company, today announced that the U.S. Patent and Trademark Office has issued to the University of Iowa Research Foundation (“UIRF”) U.S. Patent No. 11,414,704 titled COMPOSITIONS AND […]
Cardio Diagnostics, Inc. has pioneered a proprietary artificial intelligence-driven Integrated Genetic-Epigenetic Engine™ that enables improved diagnosis and prevention of cardiovascular disease The Company’s flagship product, Epi+Gen CHD™, is a highly sensitive and accessible clinical test that assesses the 3-year risk […]
Pioneer of AI-driven, epigenetics-based clinical tests for cardiovascular disease moves for Chicago’s thriving biotech ecosystem and access to talent and resources CHICAGO, May 25, 2022 /PRNewswire/ — Cardio Diagnostics, Inc. (“Cardio Diagnostics”), a company pioneering AI-driven, epigenetics-based clinical tests for cardiovascular disease (CVD), today announced they […]
On Average, 41% More Sensitive Than Current Tests for Predicting Future Heart Disease in Women CHICAGO–(BUSINESS WIRE)–Cardio Diagnostics, Inc, a biotechnology company making cardiovascular disease prevention and early detection more accessible, personalized and precise, announces the launch of its patent-pending […]
